Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00781144 · ClinicalTrials.gov registry record

Determination of Forces Used in Palpatory Diagnosis

A clinical trial, sponsored by Nova Southeastern University.

Completed
Registry status
82
Enrollment target

NCT00781144: Completed study, sponsored by Nova Southeastern University.

NCT00781144 is a clinical trial that has completed, run by Nova Southeastern University. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00781144 has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
82 participants
Enrollment target

Study Summary

In this study, we are experimentally investigating the assessment of forces used by skilled clinicians and beginning practitioners in palpatory techniques. The study will assess pressure used during palpatory diagnosis of the paraspinal region.

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2007-08
Est. Completion 2007-08
Nova Southeastern University

71 total trials

What the finished NCT00781144 record still lists

NCT00781144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00781144 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00781144 about?

NCT00781144 is a clinical study titled "Determination of Forces Used in Palpatory Diagnosis". In this study, we are experimentally investigating the assessment of forces used by skilled clinicians and beginning practitioners in palpatory techniques. The study will assess pressure used during palpatory diagnosis of the paraspinal region.

What is the current status of trial NCT00781144?

This trial is currently completed. The enrollment target is 82 participants. The study started on 2007-08. Estimated completion is 2007-08.

Who is sponsoring clinical trial NCT00781144?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03319901 · 82 participants · Phase 1

    Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

  • NCT03493425 · 82 participants · Phase 2

    Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

  • NCT04105270 · 82 participants · Phase 2

    RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

  • NCT04428658 · 82 participants · NA

    Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00781144, the US trial registry maintained by the National Library of Medicine. NCT00781144 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.